a developer of gene therapies for fatal and debilitating diseases of the central nervous system
Industry Biotechnology
A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with EDIT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then EDIT could also see price increases.
Ticker / NAME | Correlation To VYGR | 1D Price Change % | ||
---|---|---|---|---|
VYGR | 100% | -2.05% | ||
EDIT - VYGR | 44% Loosely correlated | -3.58% | ||
PLRX - VYGR | 43% Loosely correlated | -0.36% | ||
ELVN - VYGR | 41% Loosely correlated | -5.04% | ||
XNCR - VYGR | 40% Loosely correlated | -0.42% | ||
RGNX - VYGR | 39% Loosely correlated | +1.72% | ||
More |
Ticker / NAME | Correlation To VYGR | 1D Price Change % |
---|---|---|
VYGR | 100% | -2.05% |
central nervous system theme (4 stocks) | 51% Loosely correlated | -5.18% |
cancer theme (82 stocks) | 47% Loosely correlated | -2.38% |
drugs theme (254 stocks) | 44% Loosely correlated | -1.72% |
gene therapy theme (12 stocks) | 29% Poorly correlated | -4.27% |
biotechnology theme (238 stocks) | 28% Poorly correlated | -1.80% |
More |